. 2018 Sep 25;68(675):e673–e681. doi: 10.3399/bjgp18X699053

Table 2.

Changes in antidepressant medication taken during follow-up

		Baseline–3 months (n = 219)	3–6 months (n = 207)	6–9 months (n = 191)	9–12 months (n = 181)
No longer taking antidepressants (already stopped + new stops)		8	14	11	14

Still taking antidepressants		211	191	175	165

Re-started taking antidepressants		0	2	5	2

1st time point	2nd time point	Baseline–3 months (n = 203)^a	3–6 months (n = 181)^a	6–9 months (n = 170)^a	9–12 months (n = 161)^a

Monotherapy	Continued on same drug	176	156	142	131
	Same dose	147	130	113	103
	Increased dose	17	14	15	17
	Reduced dose	12	12	14	11

	Switched antidepressant	5	2	3	6
	Within class	1	1	1	2
	Between class	4	1	2	4

	Combination therapy/augmented antidepressant	5	5	4	7
	Second antidepressant^b	5	5	4	7
	Non-antidepressant augmenter	0	0	0	0

Combination therapy	Continued on combination therapy^b	14	15	15	14
	Same combination of drugs^c	14	15	14	13
	Different combination	0	0	1	1

	Change to monotherapy	3	3	6	3

Missing information on type and/or dose of antidepressant		8	10	5	4

Number of patients with data on type and dose of antidepressant medication among those still taking antidepressants.

Includes combinations where the second antidepressant is low-dose (<75 mg) amitriptyline.

Dose of medication may have changed.